197 related articles for article (PubMed ID: 32251446)
1. Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD.
Odak I; Depkat-Jakob A; Beck M; Jarek M; Yu Y; Seidler U; David S; Ganser A; Förster R; Prinz I; Koenecke C
PLoS One; 2020; 15(4):e0231222. PubMed ID: 32251446
[TBL] [Abstract][Full Text] [Related]
2. Adoptively transferred donor IL-17-producing CD4
Cai Y; Ma S; Liu Y; Gong H; Cheng Q; Hu B; Wu Y; Yu X; Dong C; Sun K; Wu D; Liu H
Cell Mol Immunol; 2018 Mar; 15(3):233-245. PubMed ID: 27748733
[TBL] [Abstract][Full Text] [Related]
3. IL-17 contributes to CD4-mediated graft-versus-host disease.
Kappel LW; Goldberg GL; King CG; Suh DY; Smith OM; Ligh C; Holland AM; Grubin J; Mark NM; Liu C; Iwakura Y; Heller G; van den Brink MR
Blood; 2009 Jan; 113(4):945-52. PubMed ID: 18931341
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
6. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
[TBL] [Abstract][Full Text] [Related]
7. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
[TBL] [Abstract][Full Text] [Related]
9. Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F.
Zhou C; Wu D; Jawale C; Li Y; Biswas PS; McGeachy MJ; Gaffen SL
Cytokine; 2021 Dec; 148():155715. PubMed ID: 34587561
[TBL] [Abstract][Full Text] [Related]
10. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
11. Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.
Varelias A; Ormerod KL; Bunting MD; Koyama M; Gartlan KH; Kuns RD; Lachner N; Locke KR; Lim CY; Henden AS; Zhang P; Clouston AD; Hasnain SZ; McGuckin MA; Blazar BR; MacDonald KP; Hugenholtz P; Hill GR
Blood; 2017 Apr; 129(15):2172-2185. PubMed ID: 28137828
[TBL] [Abstract][Full Text] [Related]
12. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
13. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
[TBL] [Abstract][Full Text] [Related]
14. A critical role for donor-derived IL-22 in cutaneous chronic GVHD.
Gartlan KH; Bommiasamy H; Paz K; Wilkinson AN; Owen M; Reichenbach DK; Banovic T; Wehner K; Buchanan F; Varelias A; Kuns RD; Chang K; Fedoriw Y; Shea T; Coghill J; Zaiken M; Plank MW; Foster PS; Clouston AD; Blazar BR; Serody JS; Hill GR
Am J Transplant; 2018 Apr; 18(4):810-820. PubMed ID: 28941323
[TBL] [Abstract][Full Text] [Related]
15. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
16. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease.
Tawara I; Maeda Y; Sun Y; Lowler KP; Liu C; Toubai T; McKenzie AN; Reddy P
Exp Hematol; 2008 Aug; 36(8):988-96. PubMed ID: 18410989
[TBL] [Abstract][Full Text] [Related]
17. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
[TBL] [Abstract][Full Text] [Related]
18. Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing T
Tang C; Kakuta S; Shimizu K; Kadoki M; Kamiya T; Shimazu T; Kubo S; Saijo S; Ishigame H; Nakae S; Iwakura Y
Nat Immunol; 2018 Jul; 19(7):755-765. PubMed ID: 29915298
[TBL] [Abstract][Full Text] [Related]
19. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
